BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16466850)

  • 21. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
    Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
    Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot.
    Van Der Heijden MS; Brody JR; Kern SE
    Cancer Biol Ther; 2004 Jun; 3(6):534-7. PubMed ID: 15107617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
    Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP
    Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.
    Romick-Rosendale LE; Hoskins EE; Privette Vinnedge LM; Foglesong GD; Brusadelli MG; Potter SS; Komurov K; Brugmann SA; Lambert PF; Kimple RJ; Virts EL; Hanenberg H; Gillison ML; Wells SI
    Clin Cancer Res; 2016 Apr; 22(8):2062-73. PubMed ID: 26603260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
    Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
    Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
    Moes-Sosnowska J; Rzepecka IK; Chodzynska J; Dansonka-Mieszkowska A; Szafron LM; Balabas A; Lotocka R; Sobiczewski P; Kupryjanczyk J
    Cancer Biol Ther; 2019; 20(6):843-854. PubMed ID: 30822218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
    Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
    Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.
    Bogliolo M; Lyakhovich A; Callén E; Castellà M; Cappelli E; Ramírez MJ; Creus A; Marcos R; Kalb R; Neveling K; Schindler D; Surrallés J
    EMBO J; 2007 Mar; 26(5):1340-51. PubMed ID: 17304220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Fanconi anemia/BRCA genes in zebrafish sex determination.
    Rodríguez-Marí A; Postlethwait JH
    Methods Cell Biol; 2011; 105():461-90. PubMed ID: 21951543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.
    Renaudin X; Rosselli F
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32466131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
    Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
    Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
    Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
    Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
    Shen X; Do H; Li Y; Chung WH; Tomasz M; de Winter JP; Xia B; Elledge SJ; Wang W; Li L
    Mol Cell; 2009 Sep; 35(5):716-23. PubMed ID: 19748364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects.
    George M; Solanki A; Chavan N; Rajendran A; Raj R; Mohan S; Nemani S; Kanvinde S; Munirathnam D; Rao S; Radhakrishnan N; Lashkari HP; Ghildhiyal RG; Manglani M; Shanmukhaiah C; Bhat S; Ramesh S; Cherian A; Junagade P; Vundinti BR
    Hum Mutat; 2021 Dec; 42(12):1648-1665. PubMed ID: 34585473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FA Core Complex Contains a Homo-dimeric Catalytic Module for the Symmetric Mono-ubiquitination of FANCI-FANCD2.
    Swuec P; Renault L; Borg A; Shah F; Murphy VJ; van Twest S; Snijders AP; Deans AJ; Costa A
    Cell Rep; 2017 Jan; 18(3):611-623. PubMed ID: 27986592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.